Skip to content
KE

Kimball Electronics, Inc.

Kimball Electronics, Inc. Q1 FY2025 earnings call

November 5, 2024 · fiscal period ended 2024-09

EPS · actual vs est

/

Revenue · actual vs est

/
Ask about this call

Summary

Generated 2024-11-05

Management highlights

  • Strategically restructured by divesting noncore AT&M business and folding medical CMO into EMS. - Sharpened strategic focus in vertical markets on areas like automotive domain controllers, industrial energy storage, and medical drug device combinations. - Proactively adjusted resources and costs due to market demand softness, lowered inventory by over $150 million, and generated positive cash flow. - Announced closure of Tampa manufacturing facility to drive efficiency, with production activities transferred to Mexico and Jasper facilities. - Q1 results in line with expectations despite challenging market conditions, adjusted selling and administrative expenses reduced by $3.5 million, and balance sheet strengthened with lower debt levels.
View in transcript ↓

Segment performance

For the first quarter of fiscal 2025, net sales totaled $374 million, a 15% decrease year-over-year (13% excluding AT&M). By vertical segment: Automotive had net sales of $188 million, down 11% YoY, accounting for 50% of total company sales. Medical had net sales of $90 million, down 12% YoY, 24% of total. Industrial had net sales of $96 million, down 22% YoY, 25% of total.

View in transcript ↓

Guidance

  • Net sales expected to be in the range of $1.44 billion to $1.54 billion for fiscal 2025. - Adjusted operating income expected to be 4% to 4.5% of net sales. - Capital expenditures预计 to be $40 million to $50 million. - Incurring approximately $8 million to $11 million in Tampa exit costs, predominantly cash expenditures. - Q2 revenue decline expected to be roughly in line with Q1, with margin improvement anticipated in the back half of the year.
View in transcript ↓

Risks

  • Market demand softness impacting vertical segments. - Challenges in managing inventory levels, especially in automotive due to long lead times. - Uncertainty around the timing of demand stabilization in end markets. - Impact of program cancellations and transitions on operations and revenue.
View in transcript ↓

Q&A highlights

Q: Can you remind us what's on the books for the Tampa facility and clarify proceeds from selling it?

A: Tampa has annual revenue of ~$75M. Proceeds from selling the building and land are expected to exceed exit costs.

Q: What's the visibility on clearing elevated inventory in auto?

A: Have regular contact with customers to update demand, but no clear line of sight on timing of demand stabilization.

Q: How should we think about gross margin trending?

A: Expected measured improvement in Q2 and more significant improvement in the back half of the year, dependent on revenue and cost reduction efforts.

Q: Is September the low watermark for revenue?

A: Likely October is the low watermark as Q2 decline is in line with Q1.

Q: Clarify sequential decline in Q2 revenue?

A: By revenue, with improved gross margin.

Q: Details on inventory in auto and remedy?

A: Automotive inventory is challenging due to long lead times; work with customers to right-size, and will fully recover inventory.

Q: Timing of Tampa exit costs?

A: Will begin process immediately, with some costs expected in Q2.

Q: Savings from Tampa closure?

A: Not disclosed yet, but utilization of other facilities will improve, and more info will be given in Q2.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS
Revenue

Transcript

November 5, 2024

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.